APO Research
Talk to an analyst

APO RESEARCH · REPORT

Infection Prevention Surveillance

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Infection Prevention Surveillance Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025192 pages

Choose your research edition.

Industry ResearchInfection Prevention Surveillance Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Infection Prevention Surveillance Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Infection Prevention Surveillance Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Infection Prevention Surveillance Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Infection Prevention Surveillance Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Infection Prevention Surveillance market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Infection Prevention Surveillance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Infection Prevention Surveillance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Infection Prevention Surveillance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Infection Prevention Surveillance is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Infection Prevention Surveillance include BD, Wolters Kluwer, Gojo Industries Inc., International Business Machines Corporation, Premier Inc., Alpha Source Inc., RLDatixS. C., Baxter International Inc. and BioVigil, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Infection Prevention Surveillance market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Infection Prevention Surveillance and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Infection Prevention Surveillance revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Infection Prevention Surveillance market size, projected growth trends, production technologies, key applications, and end-use industries.

Infection Prevention Surveillance Segment by Company

BD

Wolters Kluwer

Gojo Industries Inc.

International Business Machines Corporation

Premier Inc.

Alpha Source Inc.

RLDatixS. C.

Baxter International Inc.

BioVigil

Johnson & Son

Infection Prevention Surveillance Segment by Type

Bloodstream Infections

Surgical Site Infections

Gastrointestinal Infections

Urinary Tract Infections (UTI)

Others

Infection Prevention Surveillance Segment by Application

Hospitals & Clinics

Ambulatory Surgical Centers

Academic Institutes

Others

Infection Prevention Surveillance Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infection Prevention Surveillance market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Infection Prevention Surveillance and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infection Prevention Surveillance.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Infection Prevention Surveillance in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Infection Prevention Surveillance industry.

Chapter 3: Detailed analysis of Infection Prevention Surveillance companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Infection Prevention Surveillancerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Infection Prevention Surveillance Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Bloodstream Infections Table 3. Key Players of Surgical Site Infections Table 4. Key Players of Gastrointestinal Infections Table 3. Key Players of Urinary Tract Infections (UTI) Table 4. Key Players of Others Table 5. Global Infection Prevention Surveillance Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospitals & Clinics Table 7. Key Players of Ambulatory Surgical Centers Table 8. Key Players of Academic Institutes Table 9. Key Players of Others Table 10. Global Infection Prevention Surveillance Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Infection Prevention Surveillance Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Infection Prevention Surveillance Market Share by Region (2021-2026) Table 13. Global Infection Prevention Surveillance Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Infection Prevention Surveillance Market Share by Region (2027-2032) Table 15. Infection Prevention Surveillance Industry Trends Table 16. Infection Prevention Surveillance Industry Drivers Table 17. Infection Prevention Surveillance Industry Opportunities and Challenges Table 18. Infection Prevention Surveillance Industry Restraints Table 19. Global Infection Prevention Surveillance Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Infection Prevention Surveillance Revenue Market Share by Company (2021-2026) Table 21. Global Infection Prevention Surveillance Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Infection Prevention Surveillance Key Company Head Office and Area Served Table 23. Global Infection Prevention Surveillance Company, Product Type & Application Table 24. Global Infection Prevention Surveillance Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Infection Prevention Surveillance by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Infection Prevention Surveillance Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Infection Prevention Surveillance Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Infection Prevention Surveillance Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Infection Prevention Surveillance Revenue Market Share by Type (2021-2026) Table 31. Global Infection Prevention Surveillance Revenue Market Share by Type (2027-2032) Table 32. Global Infection Prevention Surveillance Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Infection Prevention Surveillance Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Infection Prevention Surveillance Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Infection Prevention Surveillance Revenue Market Share by Application (2021-2026) Table 36. Global Infection Prevention Surveillance Revenue Market Share by Application (2027-2032) Table 37. BD Company Information Table 38. BD Business Overview Table 39. BD Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. BD Infection Prevention Surveillance Product Portfolio Table 41. BD Recent Development Table 42. Wolters Kluwer Company Information Table 43. Wolters Kluwer Business Overview Table 44. Wolters Kluwer Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Wolters Kluwer Infection Prevention Surveillance Product Portfolio Table 46. Wolters Kluwer Recent Development Table 47. Gojo Industries Inc. Company Information Table 48. Gojo Industries Inc. Business Overview Table 49. Gojo Industries Inc. Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Gojo Industries Inc. Infection Prevention Surveillance Product Portfolio Table 51. Gojo Industries Inc. Recent Development Table 52. International Business Machines Corporation Company Information Table 53. International Business Machines Corporation Business Overview Table 54. International Business Machines Corporation Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. International Business Machines Corporation Infection Prevention Surveillance Product Portfolio Table 56. International Business Machines Corporation Recent Development Table 57. Premier Inc. Company Information Table 58. Premier Inc. Business Overview Table 59. Premier Inc. Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Premier Inc. Infection Prevention Surveillance Product Portfolio Table 61. Premier Inc. Recent Development Table 62. Alpha Source Inc. Company Information Table 63. Alpha Source Inc. Business Overview Table 64. Alpha Source Inc. Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Alpha Source Inc. Infection Prevention Surveillance Product Portfolio Table 66. Alpha Source Inc. Recent Development Table 67. RLDatixS. C. Company Information Table 68. RLDatixS. C. Business Overview Table 69. RLDatixS. C. Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. RLDatixS. C. Infection Prevention Surveillance Product Portfolio Table 71. RLDatixS. C. Recent Development Table 72. Baxter International Inc. Company Information Table 73. Baxter International Inc. Business Overview Table 74. Baxter International Inc. Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Baxter International Inc. Infection Prevention Surveillance Product Portfolio Table 76. Baxter International Inc. Recent Development Table 77. BioVigil Company Information Table 78. BioVigil Business Overview Table 79. BioVigil Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. BioVigil Infection Prevention Surveillance Product Portfolio Table 81. BioVigil Recent Development Table 82. Johnson & Son Company Information Table 83. Johnson & Son Business Overview Table 84. Johnson & Son Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Johnson & Son Infection Prevention Surveillance Product Portfolio Table 86. Johnson & Son Recent Development Table 87. North America Infection Prevention Surveillance Market Size by Type (2021-2026) & (US$ Million) Table 88. North America Infection Prevention Surveillance Market Size by Type (2027-2032) & (US$ Million) Table 89. North America Infection Prevention Surveillance Market Size by Application (2021-2026) & (US$ Million) Table 90. North America Infection Prevention Surveillance Market Size by Application (2027-2032) & (US$ Million) Table 91. North America Infection Prevention Surveillance Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Infection Prevention Surveillance Market Size by Country (2021-2026) Table 93. North America Infection Prevention Surveillance Market Size by Country (2027-2032) Table 94. Europe Infection Prevention Surveillance Market Size by Type (2021-2026) & (US$ Million) Table 95. Europe Infection Prevention Surveillance Market Size by Type (2027-2032) & (US$ Million) Table 96. Europe Infection Prevention Surveillance Market Size by Application (2021-2026) & (US$ Million) Table 97. Europe Infection Prevention Surveillance Market Size by Application (2027-2032) & (US$ Million) Table 98. Europe Infection Prevention Surveillance Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Infection Prevention Surveillance Market Size by Country (2021-2026) Table 100. Europe Infection Prevention Surveillance Market Size by Country (2027-2032) Table 101. China Infection Prevention Surveillance Market Size by Type (2021-2026) & (US$ Million) Table 102. China Infection Prevention Surveillance Market Size by Type (2027-2032) & (US$ Million) Table 103. China Infection Prevention Surveillance Market Size by Application (2021-2026) & (US$ Million) Table 104. China Infection Prevention Surveillance Market Size by Application (2027-2032) & (US$ Million) Table 105. Asia Infection Prevention Surveillance Market Size by Type (2021-2026) & (US$ Million) Table 106. Asia Infection Prevention Surveillance Market Size by Type (2027-2032) & (US$ Million) Table 107. Asia Infection Prevention Surveillance Market Size by Application (2021-2026) & (US$ Million) Table 108. Asia Infection Prevention Surveillance Market Size by Application (2027-2032) & (US$ Million) Table 109. Asia Infection Prevention Surveillance Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia Infection Prevention Surveillance Market Size by Country (2021-2026) Table 111. Asia Infection Prevention Surveillance Market Size by Country (2027-2032) Table 112. South America, Middle East & Africa Infection Prevention Surveillance Market Size by Type (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Infection Prevention Surveillance Market Size by Type (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Infection Prevention Surveillance Market Size by Application (2021-2026) & (US$ Million) Table 115. South America, Middle East & Africa Infection Prevention Surveillance Market Size by Application (2027-2032) & (US$ Million) Table 116. South America, Middle East & Africa Infection Prevention Surveillance Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. South America, Middle East & Africa Infection Prevention Surveillance Market Size by Country (2021-2026) Table 118. South America, Middle East & Africa Infection Prevention Surveillance Market Size by Country (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Infection Prevention Surveillance Product Image Figure 2. Global Infection Prevention Surveillance Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Infection Prevention Surveillance Market Share by Type: 2025 VS 2032 Figure 4. Bloodstream Infections Image Figure 5. Surgical Site Infections Image Figure 6. Gastrointestinal Infections Image Figure 7. Urinary Tract Infections (UTI) Image Figure 8. Others Image Figure 9. Global Infection Prevention Surveillance Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Infection Prevention Surveillance Market Share by Application: 2025 VS 2032 Figure 11. Hospitals & Clinics Image Figure 12. Ambulatory Surgical Centers Image Figure 13. Academic Institutes Image Figure 14. Others Image Figure 15. Global Infection Prevention Surveillance Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 17. Global Infection Prevention Surveillance Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Infection Prevention Surveillance Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Infection Prevention Surveillance Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Infection Prevention Surveillance Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Infection Prevention Surveillance Revenue Market Share by Type (2021-2032) Figure 24. Global Infection Prevention Surveillance Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Infection Prevention Surveillance Revenue Market Share by Application (2021-2032) Figure 26. North America Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 27. North America Infection Prevention Surveillance Market Share by Type (2021-2032) Figure 28. North America Infection Prevention Surveillance Market Share by Application (2021-2032) Figure 29. North America Infection Prevention Surveillance Market Share by Country (2021-2032) Figure 30. United States Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 31. Canada Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 33. Europe Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 34. Europe Infection Prevention Surveillance Market Share by Type (2021-2032) Figure 35. Europe Infection Prevention Surveillance Market Share by Application (2021-2032) Figure 36. Europe Infection Prevention Surveillance Market Share by Country (2021-2032) Figure 37. Germany Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 38. France Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 40. Italy Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 41. Russia Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 43. China Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 44. China Infection Prevention Surveillance Market Share by Type (2021-2032) Figure 45. China Infection Prevention Surveillance Market Share by Application (2021-2032) Figure 46. Asia Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 47. Asia Infection Prevention Surveillance Market Share by Type (2021-2032) Figure 48. Asia Infection Prevention Surveillance Market Share by Application (2021-2032) Figure 49. Asia Infection Prevention Surveillance Market Share by Country (2021-2032) Figure 50. Japan Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 54. India Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 55. Australia Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Infection Prevention Surveillance Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Infection Prevention Surveillance Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Infection Prevention Surveillance Market Share by Country (2021-2032) Figure 60. Brazil Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 65. UAE Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 67. Chile Infection Prevention Surveillance Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Bloodstream Infections
  • Surgical Site Infections
  • Gastrointestinal Infections
  • Urinary Tract Infections (UTI)
  • Others
Applications
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Academic Institutes
  • Others
Companies covered
  • BD
  • Wolters Kluwer
  • Gojo Industries Inc.
  • International Business Machines Corporation
  • Premier Inc.
  • Alpha Source Inc.
  • RLDatixS. C.
  • Baxter International Inc.
  • BioVigil
  • Johnson & Son

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Infection Prevention Surveillance Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Bloodstream Infections
  5. 1.2.3 Surgical Site Infections
  6. 1.2.4 Gastrointestinal Infections
  7. 1.2.5 Urinary Tract Infections (UTI)
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Infection Prevention Surveillance Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals & Clinics
  12. 1.3.3 Ambulatory Surgical Centers
  13. 1.3.4 Academic Institutes
  14. 1.3.5 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Infection Prevention Surveillance Growth Trends by Region
  17. 1.5.1 Global Infection Prevention Surveillance Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Infection Prevention Surveillance Market Size by Region (2021-2026)
  19. 1.5.3 Infection Prevention Surveillance Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Infection Prevention Surveillance Market Dynamics
  1. 2.1 Infection Prevention Surveillance Industry Trends
  2. 2.2 Infection Prevention Surveillance Industry Drivers
  3. 2.3 Infection Prevention Surveillance Industry Opportunities and Challenges
  4. 2.4 Infection Prevention Surveillance Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Infection Prevention Surveillance Revenue by Company (2021-2026)
  2. 3.2 Global Infection Prevention Surveillance Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Infection Prevention Surveillance Key Company Head office and Area Served
  4. 3.4 Global Infection Prevention Surveillance Company, Product Type & Application
  5. 3.5 Global Infection Prevention Surveillance Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Infection Prevention Surveillance Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Infection Prevention Surveillance Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Infection Prevention Surveillance Tier 1, Tier 2, and Tier 3
4 Infection Prevention Surveillance Market by Type
  1. 4.1 Global Infection Prevention Surveillance Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Infection Prevention Surveillance Market Size by Type (2021-2032)
  3. 4.3 Global Infection Prevention Surveillance Market Size Share by Type (2021-2032)
5 Infection Prevention Surveillance Market by Application
  1. 5.1 Global Infection Prevention Surveillance Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Infection Prevention Surveillance Market Size by Application (2021-2032)
  3. 5.3 Global Infection Prevention Surveillance Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 BD
  2. 6.1.1 BD Company Information
  3. 6.1.2 BD Business Overview
  4. 6.1.3 BD Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 BD Infection Prevention Surveillance Product Portfolio
  6. 6.1.5 BD Recent Developments
  7. 6.2 Wolters Kluwer
  8. 6.2.1 Wolters Kluwer Company Information
  9. 6.2.2 Wolters Kluwer Business Overview
  10. 6.2.3 Wolters Kluwer Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Wolters Kluwer Infection Prevention Surveillance Product Portfolio
  12. 6.2.5 Wolters Kluwer Recent Developments
  13. 6.3 Gojo Industries Inc.
  14. 6.3.1 Gojo Industries Inc. Company Information
  15. 6.3.2 Gojo Industries Inc. Business Overview
  16. 6.3.3 Gojo Industries Inc. Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Gojo Industries Inc. Infection Prevention Surveillance Product Portfolio
  18. 6.3.5 Gojo Industries Inc. Recent Developments
  19. 6.4 International Business Machines Corporation
  20. 6.4.1 International Business Machines Corporation Company Information
  21. 6.4.2 International Business Machines Corporation Business Overview
  22. 6.4.3 International Business Machines Corporation Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 International Business Machines Corporation Infection Prevention Surveillance Product Portfolio
  24. 6.4.5 International Business Machines Corporation Recent Developments
  25. 6.5 Premier Inc.
  26. 6.5.1 Premier Inc. Company Information
  27. 6.5.2 Premier Inc. Business Overview
  28. 6.5.3 Premier Inc. Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Premier Inc. Infection Prevention Surveillance Product Portfolio
  30. 6.5.5 Premier Inc. Recent Developments
  31. 6.6 Alpha Source Inc.
  32. 6.6.1 Alpha Source Inc. Company Information
  33. 6.6.2 Alpha Source Inc. Business Overview
  34. 6.6.3 Alpha Source Inc. Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Alpha Source Inc. Infection Prevention Surveillance Product Portfolio
  36. 6.6.5 Alpha Source Inc. Recent Developments
  37. 6.7 RLDatixS. C.
  38. 6.7.1 RLDatixS. C. Company Information
  39. 6.7.2 RLDatixS. C. Business Overview
  40. 6.7.3 RLDatixS. C. Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 RLDatixS. C. Infection Prevention Surveillance Product Portfolio
  42. 6.7.5 RLDatixS. C. Recent Developments
  43. 6.8 Baxter International Inc.
  44. 6.8.1 Baxter International Inc. Company Information
  45. 6.8.2 Baxter International Inc. Business Overview
  46. 6.8.3 Baxter International Inc. Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Baxter International Inc. Infection Prevention Surveillance Product Portfolio
  48. 6.8.5 Baxter International Inc. Recent Developments
  49. 6.9 BioVigil
  50. 6.9.1 BioVigil Company Information
  51. 6.9.2 BioVigil Business Overview
  52. 6.9.3 BioVigil Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 BioVigil Infection Prevention Surveillance Product Portfolio
  54. 6.9.5 BioVigil Recent Developments
  55. 6.10 Johnson & Son
  56. 6.10.1 Johnson & Son Company Information
  57. 6.10.2 Johnson & Son Business Overview
  58. 6.10.3 Johnson & Son Infection Prevention Surveillance Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Johnson & Son Infection Prevention Surveillance Product Portfolio
  60. 6.10.5 Johnson & Son Recent Developments
7 North America
  1. 7.1 North America Infection Prevention Surveillance Market Size (2021-2032)
  2. 7.2 North America Infection Prevention Surveillance Market Size by Type
  3. 7.2.1 North America Infection Prevention Surveillance Market Size by Type (2021-2026)
  4. 7.2.2 North America Infection Prevention Surveillance Market Size by Type (2027-2032)
  5. 7.2.3 North America Infection Prevention Surveillance Market Share by Type (2021-2032)
  6. 7.3 North America Infection Prevention Surveillance Market Size by Application
  7. 7.3.1 North America Infection Prevention Surveillance Market Size by Application (2021-2026)
  8. 7.3.2 North America Infection Prevention Surveillance Market Size by Application (2027-2032)
  9. 7.3.3 North America Infection Prevention Surveillance Market Share by Application (2021-2032)
  10. 7.4 North America Infection Prevention Surveillance Market Size by Country
  11. 7.4.1 North America Infection Prevention Surveillance Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Infection Prevention Surveillance Market Size by Country (2021-2026)
  13. 7.4.3 North America Infection Prevention Surveillance Market Size by Country (2027-2032)
  14. 7.4.4 North America Infection Prevention Surveillance Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Infection Prevention Surveillance Market Size (2021-2032)
  2. 8.2 Europe Infection Prevention Surveillance Market Size by Type
  3. 8.2.1 Europe Infection Prevention Surveillance Market Size by Type (2021-2026)
  4. 8.2.2 Europe Infection Prevention Surveillance Market Size by Type (2027-2032)
  5. 8.2.3 Europe Infection Prevention Surveillance Market Share by Type (2021-2032)
  6. 8.3 Europe Infection Prevention Surveillance Market Size by Application
  7. 8.3.1 Europe Infection Prevention Surveillance Market Size by Application (2021-2026)
  8. 8.3.2 Europe Infection Prevention Surveillance Market Size by Application (2027-2032)
  9. 8.3.3 Europe Infection Prevention Surveillance Market Share by Application (2021-2032)
  10. 8.4 Europe Infection Prevention Surveillance Market Size by Country
  11. 8.4.1 Europe Infection Prevention Surveillance Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Infection Prevention Surveillance Market Size by Country (2021-2026)
  13. 8.4.3 Europe Infection Prevention Surveillance Market Size by Country (2027-2032)
  14. 8.4.4 Europe Infection Prevention Surveillance Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Infection Prevention Surveillance Market Size (2021-2032)
  2. 9.2 China Infection Prevention Surveillance Market Size by Type
  3. 9.2.1 China Infection Prevention Surveillance Market Size by Type (2021-2026)
  4. 9.2.2 China Infection Prevention Surveillance Market Size by Type (2027-2032)
  5. 9.2.3 China Infection Prevention Surveillance Market Share by Type (2021-2032)
  6. 9.3 China Infection Prevention Surveillance Market Size by Application
  7. 9.3.1 China Infection Prevention Surveillance Market Size by Application (2021-2026)
  8. 9.3.2 China Infection Prevention Surveillance Market Size by Application (2027-2032)
  9. 9.3.3 China Infection Prevention Surveillance Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Infection Prevention Surveillance Market Size (2021-2032)
  2. 10.2 Asia Infection Prevention Surveillance Market Size by Type
  3. 10.2.1 Asia Infection Prevention Surveillance Market Size by Type (2021-2026)
  4. 10.2.2 Asia Infection Prevention Surveillance Market Size by Type (2027-2032)
  5. 10.2.3 Asia Infection Prevention Surveillance Market Share by Type (2021-2032)
  6. 10.3 Asia Infection Prevention Surveillance Market Size by Application
  7. 10.3.1 Asia Infection Prevention Surveillance Market Size by Application (2021-2026)
  8. 10.3.2 Asia Infection Prevention Surveillance Market Size by Application (2027-2032)
  9. 10.3.3 Asia Infection Prevention Surveillance Market Share by Application (2021-2032)
  10. 10.4 Asia Infection Prevention Surveillance Market Size by Country
  11. 10.4.1 Asia Infection Prevention Surveillance Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Infection Prevention Surveillance Market Size by Country (2021-2026)
  13. 10.4.3 Asia Infection Prevention Surveillance Market Size by Country (2027-2032)
  14. 10.4.4 Asia Infection Prevention Surveillance Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Infection Prevention Surveillance Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Infection Prevention Surveillance Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Infection Prevention Surveillance Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Infection Prevention Surveillance Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Infection Prevention Surveillance Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Infection Prevention Surveillance Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Infection Prevention Surveillance Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Infection Prevention Surveillance Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Infection Prevention Surveillance Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Infection Prevention Surveillance Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Infection Prevention Surveillance Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Infection Prevention Surveillance Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Infection Prevention Surveillance Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Infection Prevention Surveillance Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst